- call +1-201-465-4211
- email sales@mrinsights.biz
Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. The global pneumonia therapeutics market is projected to expand at a significant pace during the forecast period, due to increase in the number of cases of pneumonia and advancement in treatments. Moreover, growing awareness about pneumonia treatment among patients, rising demand for treatment, increasing incidence of pneumonia, and improvement in diagnosis methods are promoting the growth of the global pneumonia therapeutics market.
Scope of the Report:
This report studies the Pneumonia market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pneumonia market by product type and applications/end industries.
Increase in number of resistant strains and high rate of mortality & morbidity associated with pneumococcal infection have led to increased preference for prevention therapy. The high preventive rates of these vaccines, 5-year immunization schedule, and increasing support for vaccination by various regulatory agencies are expected to provide lucrative growth opportunities.
The global Pneumonia market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pneumonia.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Pfizer
GlaxoSmithKline(GSK)
Merck
Novartis
Sanofi
Eli Lilly
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Drugs
Vaccines
Oxygen Therapy
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Pneumonia Market Overview
1.1 Product Overview and Scope of Pneumonia
1.2 Classification of Pneumonia by Types
1.2.1 Global Pneumonia Revenue Comparison by Types (2017-2023)
1.2.2 Global Pneumonia Revenue Market Share by Types in 2017
1.2.3 Drugs
1.2.4 Vaccines
1.2.5 Oxygen Therapy
1.3 Global Pneumonia Market by Application
1.3.1 Global Pneumonia Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Pneumonia Market by Regions
1.4.1 Global Pneumonia Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Pneumonia Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Pneumonia Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pneumonia Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Pneumonia Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pneumonia Status and Prospect (2013-2023)
1.5 Global Market Size of Pneumonia (2013-2023)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Pneumonia Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Pneumonia Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline(GSK)
2.2.1 Business Overview
2.2.2 Pneumonia Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline(GSK) Pneumonia Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Pneumonia Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Pneumonia Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Pneumonia Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Pneumonia Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Pneumonia Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Pneumonia Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Pneumonia Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Pneumonia Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pneumonia Market Competition, by Players
3.1 Global Pneumonia Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Pneumonia Players Market Share
3.2.2 Top 10 Pneumonia Players Market Share
3.3 Market Competition Trend
4 Global Pneumonia Market Size by Regions
4.1 Global Pneumonia Revenue and Market Share by Regions
4.2 North America Pneumonia Revenue and Growth Rate (2013-2018)
4.3 Europe Pneumonia Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Pneumonia Revenue and Growth Rate (2013-2018)
4.5 South America Pneumonia Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Pneumonia Revenue and Growth Rate (2013-2018)
5 North America Pneumonia Revenue by Countries
5.1 North America Pneumonia Revenue by Countries (2013-2018)
5.2 USA Pneumonia Revenue and Growth Rate (2013-2018)
5.3 Canada Pneumonia Revenue and Growth Rate (2013-2018)
5.4 Mexico Pneumonia Revenue and Growth Rate (2013-2018)
6 Europe Pneumonia Revenue by Countries
6.1 Europe Pneumonia Revenue by Countries (2013-2018)
6.2 Germany Pneumonia Revenue and Growth Rate (2013-2018)
6.3 UK Pneumonia Revenue and Growth Rate (2013-2018)
6.4 France Pneumonia Revenue and Growth Rate (2013-2018)
6.5 Russia Pneumonia Revenue and Growth Rate (2013-2018)
6.6 Italy Pneumonia Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Pneumonia Revenue by Countries
7.1 Asia-Pacific Pneumonia Revenue by Countries (2013-2018)
7.2 China Pneumonia Revenue and Growth Rate (2013-2018)
7.3 Japan Pneumonia Revenue and Growth Rate (2013-2018)
7.4 Korea Pneumonia Revenue and Growth Rate (2013-2018)
7.5 India Pneumonia Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Pneumonia Revenue and Growth Rate (2013-2018)
8 South America Pneumonia Revenue by Countries
8.1 South America Pneumonia Revenue by Countries (2013-2018)
8.2 Brazil Pneumonia Revenue and Growth Rate (2013-2018)
8.3 Argentina Pneumonia Revenue and Growth Rate (2013-2018)
8.4 Colombia Pneumonia Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Pneumonia by Countries
9.1 Middle East and Africa Pneumonia Revenue by Countries (2013-2018)
9.2 Saudi Arabia Pneumonia Revenue and Growth Rate (2013-2018)
9.3 UAE Pneumonia Revenue and Growth Rate (2013-2018)
9.4 Egypt Pneumonia Revenue and Growth Rate (2013-2018)
9.5 Nigeria Pneumonia Revenue and Growth Rate (2013-2018)
9.6 South Africa Pneumonia Revenue and Growth Rate (2013-2018)
10 Global Pneumonia Market Segment by Type
10.1 Global Pneumonia Revenue and Market Share by Type (2013-2018)
10.2 Global Pneumonia Market Forecast by Type (2018-2023)
10.3 Drugs Revenue Growth Rate (2013-2023)
10.4 Vaccines Revenue Growth Rate (2013-2023)
10.5 Oxygen Therapy Revenue Growth Rate (2013-2023)
11 Global Pneumonia Market Segment by Application
11.1 Global Pneumonia Revenue Market Share by Application (2013-2018)
11.2 Pneumonia Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Pneumonia Market Size Forecast (2018-2023)
12.1 Global Pneumonia Market Size Forecast (2018-2023)
12.2 Global Pneumonia Market Forecast by Regions (2018-2023)
12.3 North America Pneumonia Revenue Market Forecast (2018-2023)
12.4 Europe Pneumonia Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Pneumonia Revenue Market Forecast (2018-2023)
12.6 South America Pneumonia Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Pneumonia Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Pneumonia Picture
Table Product Specifications of Pneumonia
Table Global Pneumonia and Revenue (Million USD) Market Split by Product Type
Figure Global
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
